CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 145 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,084,180 | -44.8% | 434,917 | -36.6% | 0.00% | 0.0% |
| Q2 2023 | $9,215,875 | -26.0% | 685,705 | -8.7% | 0.00% | -50.0% |
| Q1 2023 | $12,457,000 | +58356.1% | 751,353 | -34.4% | 0.00% | -33.3% |
| Q4 2022 | $21,310 | -99.9% | 1,145,707 | -13.9% | 0.00% | +50.0% |
| Q3 2022 | $17,063,000 | +116.2% | 1,329,992 | +18.1% | 0.00% | +100.0% |
| Q2 2022 | $7,893,000 | -19.8% | 1,125,833 | -5.2% | 0.00% | 0.0% |
| Q1 2022 | $9,841,000 | +21.4% | 1,187,119 | -0.9% | 0.00% | 0.0% |
| Q4 2021 | $8,108,000 | +30.3% | 1,197,784 | +2.0% | 0.00% | 0.0% |
| Q3 2021 | $6,224,000 | -18.7% | 1,174,366 | -11.8% | 0.00% | 0.0% |
| Q2 2021 | $7,654,000 | +202.9% | 1,331,083 | +142.8% | 0.00% | – |
| Q1 2021 | $2,527,000 | +16.9% | 548,213 | -15.3% | 0.00% | – |
| Q4 2020 | $2,161,000 | -2.2% | 647,046 | -6.0% | 0.00% | – |
| Q3 2020 | $2,209,000 | -35.0% | 688,008 | -6.4% | 0.00% | -100.0% |
| Q2 2020 | $3,396,000 | +11.4% | 735,230 | -7.2% | 0.00% | 0.0% |
| Q1 2020 | $3,048,000 | -12.4% | 791,864 | -14.6% | 0.00% | 0.0% |
| Q4 2019 | $3,478,000 | -33.7% | 927,352 | -6.2% | 0.00% | 0.0% |
| Q3 2019 | $5,249,000 | +47.1% | 988,575 | +3.3% | 0.00% | 0.0% |
| Q2 2019 | $3,569,000 | -25.4% | 956,946 | +2.0% | 0.00% | 0.0% |
| Q1 2019 | $4,786,000 | +165.4% | 938,476 | -0.1% | 0.00% | – |
| Q4 2018 | $1,803,000 | -51.8% | 939,138 | -5.0% | 0.00% | -100.0% |
| Q3 2018 | $3,739,000 | +32.8% | 989,080 | +9.6% | 0.00% | 0.0% |
| Q2 2018 | $2,816,000 | +2.2% | 902,388 | -21.7% | 0.00% | 0.0% |
| Q1 2018 | $2,756,000 | -50.6% | 1,153,053 | -19.2% | 0.00% | 0.0% |
| Q4 2017 | $5,579,000 | +48.4% | 1,426,920 | -5.5% | 0.00% | 0.0% |
| Q3 2017 | $3,759,000 | -11.3% | 1,509,500 | -1.7% | 0.00% | 0.0% |
| Q2 2017 | $4,240,000 | +2635.5% | 1,536,300 | +1833.2% | 0.00% | – |
| Q1 2017 | $155,000 | -76.4% | 79,470 | -85.9% | 0.00% | – |
| Q1 2016 | $658,000 | -55.4% | 562,600 | -6.6% | 0.00% | – |
| Q4 2015 | $1,476,000 | -29.6% | 602,300 | -13.9% | 0.00% | -100.0% |
| Q3 2015 | $2,098,000 | – | 699,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |